[Emergence of glycopeptide resistant Enterococcus faecium in Algeria: a case report]

Ann Biol Clin (Paris). 2013 Jan-Feb;71(1):104-6. doi: 10.1684/abc.2012.0781.
[Article in French]

Abstract

A glycopeptide-resistant Enterococcus faecium (EFRG) was isolated from a wound in a patient hospitalized in a university hospital in Algiers. This strain was resistant to several antibiotics. This patient was carrying this strain in the digestive tract which may partly explain its origin. Genotypic comparison of the two strains by pulsed field gel electrophoresis showed that it was the same strain. Glycopeptide resistance was due to the presence of the vanA gene. Vigilance is required facing the emergence of strains of EFRG in our hospitals.

Keywords: Algeria; Enterococcus faecium; glycopeptide-resistant Enterococci; vanA gene.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Algeria
  • Anti-Bacterial Agents / therapeutic use
  • Communicable Diseases, Emerging / diagnosis*
  • Communicable Diseases, Emerging / microbiology
  • Drug Resistance, Bacterial*
  • Enterococcus faecium / drug effects
  • Enterococcus faecium / isolation & purification*
  • Enterococcus faecium / physiology
  • Glycopeptides / therapeutic use*
  • Gram-Positive Bacterial Infections / diagnosis*
  • Gram-Positive Bacterial Infections / microbiology
  • Humans
  • Male
  • Microbial Sensitivity Tests
  • Young Adult

Substances

  • Anti-Bacterial Agents
  • Glycopeptides